Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $35 | $42 | $58 | $71 |
| - Cash | $14 | $14 | $16 | $10 |
| + Debt | $32 | $30 | $30 | $24 |
| Enterprise Value | $53 | $58 | $72 | $85 |
| Revenue | $41 | $41 | $44 | $39 |
| % Growth | -0.8% | -5.8% | 12.7% | – |
| Gross Profit | $20 | $20 | $21 | $19 |
| % Margin | 48% | 47.8% | 47.3% | 48.1% |
| EBITDA | $9 | $6 | $8 | $9 |
| % Margin | 20.9% | 13.4% | 17.9% | 22.6% |
| Net Income | $3 | $2 | $4 | $5 |
| % Margin | 6.7% | 5.8% | 8.5% | 12.1% |
| EPS Diluted | 1.04 | 0.89 | 1.43 | 1.85 |
| % Growth | 16.9% | -37.8% | -22.7% | – |
| Operating Cash Flow | $4 | $3 | $4 | $4 |
| Capital Expenditures | -$4 | -$5 | -$6 | -$5 |
| Free Cash Flow | $0 | -$2 | -$2 | -$1 |